Idiopathic hypersomnia symptoms over Time: Longitudinal follow up from the Hypersomnia Foundation registry
- 1 June 2025
- journal article
- Published by Elsevier in Sleep Medicine
- Vol. 133, 106627
Abstract
No abstract availableKeywords
Funding Information
- American Academy of Sleep Medicine (R01 NS111280)
- American Academy of Sleep Medicine Foundation
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
This publication has 49 references indexed in Scilit:
- Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority TrialCNS Drugs, 2024
- Validation and performance of the sleep inertia questionnaire in central disorders of hypersomnolenceSleep Medicine, 2024
- Clinical considerations in the treatment of idiopathic hypersomniaSleep Medicine, 2024
- Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registrySleep Medicine, 2020
- Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the detailsAnnals of Neurology, 2017
- HypersomniaSleep Medicine Clinics, 2017
- Idiopathic hypersomniaSleep Medicine Reviews, 2016
- Diurnal and nocturnal cardiovascular variability and heart rate arousal response in idiopathic hypersomniaSleep Medicine, 2016
- Absence of γ‐aminobutyric acid‐a receptor potentiation in central hypersomnolence disordersAnnals of Neurology, 2016
- Clarithromycin in γ‐aminobutyric acid–Related hypersomnolence: A randomized, crossover trialAnnals of Neurology, 2015